<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38146040</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1618-7601</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The European journal of health economics : HEPAC : health economics in prevention and care</Title><ISOAbbreviation>Eur J Health Econ</ISOAbbreviation></Journal><ArticleTitle>Impact of Long COVID on productivity and informal caregiving.</ArticleTitle><Pagination><StartPage>1095</StartPage><EndPage>1115</EndPage><MedlinePgn>1095-1115</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10198-023-01653-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Around 2 million people in the UK suffer from Long COVID (LC). Of concern is the disease impact on productivity and informal care burden. This study aimed to quantify and value productivity losses and informal care receipt in a sample of LC patients in the UK.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The target population comprised LC patients referred to LC specialist clinics. The questionnaires included a health economics questionnaire (HEQ) measuring productivity impacts, informal care receipt and service utilisation, EQ-5D-5L, C19-YRS LC condition-specific measure, and sociodemographic and COVID-19 history variables. Outcomes were changes from the incident infection resulting in LC to the month preceding the survey in paid work status/h, work income, work performance and informal care receipt. The human capital approach valued productivity losses; the proxy goods method valued caregiving hours. The values were extrapolated nationally using published prevalence data. Multilevel regressions, nested by region, estimated associations between the outcomes and patient characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">366 patients responded to HEQ (mean LC duration 449.9&#xa0;days). 51.7% reduced paid work hours relative to the pre-infection period. Mean monthly work income declined by 24.5%. The average aggregate value of productivity loss since incident infection was &#xa3;10,929 (95% bootstrap confidence interval &#xa3;8,844-&#xa3;13,014) and &#xa3;5.7 billion (&#xa3;3.8-&#xa3;7.6 billion) extrapolated nationally. The corresponding values for informal caregiving were &#xa3;8,726 (&#xa3;6,247-&#xa3;11,204) and &#xa3;4.8 billion (&#xa3;2.6-&#xa3;7.0 billion). Multivariate analyses found significant associations between each outcome and health utility and C19-YRS subscale scores.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LC significantly impacts productivity losses and provision of informal care, exacerbated by high national prevalence of LC.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2860-7280</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England. joseph.kwon@phc.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milne</LastName><ForeName>Ruairidh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5117-4380</Identifier><AffiliationInfo><Affiliation>Public Health, Wessex Institute, University of Southampton, Southampton, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Clare</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5167-6903</Identifier><AffiliationInfo><Affiliation>Locomotion Patient Advisory Group (Co-Lead), University of Leeds, Leeds, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha Lawrence</LastName><ForeName>Rom&#xe1;n</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1913-9825</Identifier><AffiliationInfo><Affiliation>, ELAROS 24/7 Ltd, Sheffield, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullard</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2712-6626</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Leeds, Leeds, England.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sociology, University of Durham, Durham, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir</LastName><ForeName>Ghazala</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5277-6885</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Leeds, Leeds, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3518-0131</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrou</LastName><ForeName>Stavros</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3121-6050</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV-LT2-0016</GrantID><Agency>National Institute for Health and Care Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Health Econ</MedlineTA><NlmUniqueID>101134867</NlmUniqueID><ISSNLinking>1618-7598</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004526" MajorTopicYN="Y">Efficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017028" MajorTopicYN="Y">Caregivers</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health economic evaluation</Keyword><Keyword MajorTopicYN="N">Informal caregiver burden</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Productivity</Keyword></KeywordList><CoiStatement>The authors have no competing financial and non-financial interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>23</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38146040</ArticleId><ArticleId IdType="pmc">PMC11377524</ArticleId><ArticleId IdType="doi">10.1007/s10198-023-01653-z</ArticleId><ArticleId IdType="pii">10.1007/s10198-023-01653-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, Royal College of General Practitioners. COVID-19 rapid guideline: managing the long-term effects of COVID-19. In: NICE R, and SIGN, editor. 2022.</Citation></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30 March 2023. 2023.</Citation></Reference><Reference><Citation>Sivan, M., Preston, N., Parkin, A., Makower, S., Gee, J., Ross, D., et al.: The modified COVID-19 Yorkshire rehabilitation scale (C19-YRSm) patient-reported outcome measure for long covid or post-COVID-19 syndrome. J. Med. Virol. 94(9), 4253&#x2013;4264 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce, J.D., Shen, Q., Cintron, S.A., Hiebert, J.B.: Post-COVID-19 syndrome. Nurs. Res. 71(2), 164&#x2013;174 (2022)</Citation><ArticleIdList><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, A., Hastie, C., et al.: Characterising long COVID: a living systematic review. BMJ Glob. Health 6(9), e005427 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. Bmj. 2022; 377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, D.A., O&#x2019;Brien, K.K.: Conceptualising long COVID as an episodic health condition. BMJ Glob. Health 6(9), e007004 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>All-Party Parliamentary Group. Long COVID Report March 2022. In: Group A-PP, editor. 2022.</Citation></Reference><Reference><Citation>Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., Re&#x2019;em, Y., et al.: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 38, 101019 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, S., Goodfellow, H., Pookarnjanamorakot, P., Murray, E., Bindman, J., Blandford, A., et al.: Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study. BMJ Open 13(6), e069217 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="pubmed">37286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschke D, Houston D. The impact of Long COVID on the UK workforce. Applied Economics Letters. 2022:1&#x2013;5.</Citation></Reference><Reference><Citation>Kerksieck P, Ballouz T, Haile SR, Schumacher C, Lacy J, Domenghino A, et al. Post COVID-19 condition, work ability and occupational changes in a population-based cohort. The Lancet Regional Health&#x2013;Europe. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10287546</ArticleId><ArticleId IdType="pubmed">37366496</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso, C., Cuevas, C., Oliver-Mas, S., D&#xed;ez-Cirarda, M., Delgado-&#xc1;lvarez, A., Gil-Moreno, M.J., et al.: Fatigue and cognitive dysfunction are associated with occupational status in post-COVID syndrome. Int. J. Environ. Res. Public Health 19(20), 13368 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9603617</ArticleId><ArticleId IdType="pubmed">36293950</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnavita, N., Arnesano, G., Di Prinzio, R.R., Gasbarri, M., Meraglia, I., Merella, M., et al.: Post-COVID symptoms in occupational cohorts: effects on health and work ability. Int. J. Environ. Res. Public Health 20(9), 5638 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10178744</ArticleId><ArticleId IdType="pubmed">37174158</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Go&#xeb;rtz YM, Van Herck M, Machado FV, Meys R, Delbressine JM, et al. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ open research. 2021;7 (2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind, E., Palstam, A., Sunnerhagen, K.S., Persson, H.C.: Patterns and predictors of sick leave after COVID-19 and long COVID in a national Swedish cohort. BMC Public Health 21(1), 1&#x2013;9 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso, D., Gualano, M.R., Rossi, M.F., Valz Gris, A., Sisti, L.G., Borrelli, I., et al.: Post-acute COVID-19 sequelae in a working population at one year follow-Up: a wide range of impacts from an italian sample. Int. J. Environ. Res. Public Health 19(17), 11093 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9518581</ArticleId><ArticleId IdType="pubmed">36078808</ArticleId></ArticleIdList></Reference><Reference><Citation>Diem, L., Schwarzwald, A., Friedli, C., Hammer, H., Gomes-Fregolente, L., Warncke, J., et al.: Multidimensional phenotyping of the post-COVID-19 syndrome: a swiss survey study. CNS Neurosci. Ther. 28(12), 1953&#x2013;1963 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538958</ArticleId><ArticleId IdType="pubmed">35975339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden, M., Mudara, C., Vika, C., Blumberg, L., Mayet, N., Cohen, C., et al.: Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob. Health 10(9), e1247&#x2013;e1256 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisiel MA, Janols H, Nordqvist T, Bergquist J, Hagfeldt S, Malinovschi A, et al. Predictors of post-COVID-19 and the impact of persistent symptoms in non-hospitalized patients 12 months after COVID-19, with a focus on work ability. Upsala Journal of Medical Sciences. 2022; 127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383047</ArticleId><ArticleId IdType="pubmed">35991464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunt J, Hemming S, Burton K, Elander J, Baraniak A. What workers can tell us about post-COVID workability. Occupational Medicine (Oxford, England). 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384751</ArticleId><ArticleId IdType="pubmed">35968657</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazer B, Feldman DE. Functional limitations in individuals with long COVID. Archives of Physical Medicine and Rehabilitation. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10036292</ArticleId><ArticleId IdType="pubmed">36966957</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak, K., Pedersen, J., Gunnarsson, D., Roikjer, T., Podlekareva, D., Hansen, H., et al.: Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life. J. Affect. Disord. 324, 162&#x2013;169 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9795797</ArticleId><ArticleId IdType="pubmed">36586593</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Trujillo KL, Safarpour A, Santillana M, Ognyanova K, Druckman J, et al. Association of post&#x2013;COVID-19 condition symptoms and employment status. JAMA network open 2023; 6 (2): e2256152-e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone, D., Tassinari, A., Valentinotti, R., Kontogiannis, D., Ronchese, F., Centonze, S., et al.: Persistence of symptoms 15 months since COVID-19 diagnosis: prevalence, risk factors and residual work ability. Life. 13(1), 97 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9862952</ArticleId><ArticleId IdType="pubmed">36676046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin, D., Margalit, I., Nehme, M., Bordas-Mart&#xed;nez, J., Pistelli, F., Yahav, D., et al.: Patterns of long COVID symptoms: a multi-center cross sectional study. J. Clin. Med. 11(4), 898 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875229</ArticleId><ArticleId IdType="pubmed">35207171</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wambeke, E., Bezler, C., Kasprowicz, A.-M., Charles, A.-L., Andres, E., Geny, B.: Two-years follow-up of symptoms and return to work in complex post-COVID-19 patients. J. Clin. Med. 12(3), 741 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917586</ArticleId><ArticleId IdType="pubmed">36769389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen, N., Gurdasani, D., O&#x2019;Hara, M.E., Hastie, C., Roderick, P., Yao, G., et al.: Characteristics and impact of long covid: findings from an online survey. PLoS ONE 17(3), e0264331 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer, K., Reade, J.J., Schmal, W.B.: What cannot be cured must be endured: the long-lasting effect of a COVID-19 infection on workplace productivity. Labour Econ. 79, 102281 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9535936</ArticleId><ArticleId IdType="pubmed">36217320</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouad MM, Zawilla NH, Maged LA. Work performance among healthcare workers with post COVID-19 syndrome and its relation to antibody response. Infection. 2022: 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9617233</ArticleId><ArticleId IdType="pubmed">36308638</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme, M., Vieux, L., Kaiser, L., Chappuis, F., Chenaud, C., Guessous, I.: The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic toll. Sci. Rep. 13(1), 10759 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10319731</ArticleId><ArticleId IdType="pubmed">37402726</ArticleId></ArticleIdList></Reference><Reference><Citation>Levkovich, I., Kalimi, E.: Long COVID-19 symptoms among recovered teachers in israel: a mixed-methods study. COVID. 3(4), 480&#x2013;493 (2023)</Citation></Reference><Reference><Citation>Peters, C., Dulon, M., Westermann, C., Kozak, A., Nienhaus, A.: Long-term effects of COVID-19 on workers in health and social services in Germany. Int. J. Environ. Res. Public Health 19(12), 6983 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9222999</ArticleId><ArticleId IdType="pubmed">35742231</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlgren G, Whitehead M. European strategies for tackling social inequities in health: Levelling up Part 2. WHO Regional office for Europe Copenhagen; 2006.</Citation></Reference><Reference><Citation>Department of Health. Healthy lives, healthy people: Our strategy for public health in England: The Stationery Office; 2010.</Citation></Reference><Reference><Citation>Mure&#x219;an, G.-M., V&#x103;idean, V.-L., Mare, C., Achim, M.V.: Were we happy and we didn&#x2019;t know it? a subjective dynamic and financial assessment pre-, during and post-COVID-19. Eur. J. Health Econ. 24(5), 749&#x2013;768 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9390109</ArticleId><ArticleId IdType="pubmed">35984544</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohwedder, S., Willis, R.J.: Mental retirement. J. Econ. Perspect. 24(1), 119&#x2013;138 (2010)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2958696</ArticleId><ArticleId IdType="pubmed">20975927</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Older people: independence and mental wellbeing. NICE guideline [NG32] 2015 [updated 17 December 2015]. Available from: https://www.nice.org.uk/guidance/ng32.</Citation></Reference><Reference><Citation>Cook J. The socio&#x2010;economic contribution of older people in the UK. Working with Older People. 2011.</Citation></Reference><Reference><Citation>NHS England. National Commissioning Guidance for Post COVID Services. In: England N, editor. Version 3, July 20222022.</Citation></Reference><Reference><Citation>Cohen, S.A., Kunicki, Z.J., Drohan, M.M., Greaney, M.L.: Exploring changes in caregiver burden and caregiving intensity due to COVID-19. Geront Geriatric Med. 7, 2333721421999279 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919204</ArticleId><ArticleId IdType="pubmed">33718523</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmanschap, M.A., van Exel, N.J.A., van den Berg, B., Brouwer, W.B.: An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics 26(4), 269&#x2013;280 (2008)</Citation><ArticleIdList><ArticleId IdType="pubmed">18370563</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Exel, J., Bobinac, A., Koopmanschap, M., Brouwer, W.: The invisible hands made visible: recognizing the value of informal care in healthcare decision-making. Expert Rev. Pharmacoecon. Outcomes Res. 8(6), 557&#x2013;561 (2008)</Citation><ArticleIdList><ArticleId IdType="pubmed">20528366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepparulo, A., Giuriato, L.: The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies. Eur. J. Health Econ. 23(4), 671&#x2013;685 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8549427</ArticleId><ArticleId IdType="pubmed">34705129</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn, R., Moulds, D., Squires, D., Doty, M.M., Anderson, C.: International survey of older adults finds shortcomings in access, coordination, and patient-centered care. Health Aff. 33(12), 2247&#x2013;2255 (2014)</Citation><ArticleIdList><ArticleId IdType="pubmed">25410260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello, Jd.A., Macq, J., Van Durme, T., C&#xe8;s, S., Spruytte, N., Van Audenhove, C., et al.: The determinants of informal caregivers&#x2019; burden in the care of frail older persons: a dynamic and role-related perspective. Aging Mental Health. 21(8), 838&#x2013;843 (2017)</Citation><ArticleIdList><ArticleId IdType="pubmed">27054404</ArticleId></ArticleIdList></Reference><Reference><Citation>Krol, M., Brouwer, W.: How to estimate productivity costs in economic evaluations. Pharmacoeconomics 32(4), 335&#x2013;344 (2014)</Citation><ArticleIdList><ArticleId IdType="pubmed">24504850</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong T. Broadening the perspective of economic evaluation in health care - A case study in dementia care in the UK: University of Sheffield; 2017.</Citation></Reference><Reference><Citation>Squires, H., Chilcott, J., Akehurst, R., Burr, J., Kelly, M.P.: A systematic literature review of the key challenges for developing the structure of public health economic models. Int. J. Public Health 61(3), 289&#x2013;298 (2016)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4879162</ArticleId><ArticleId IdType="pubmed">26747470</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan, M., Greenhalgh, T., Darbyshire, J.L., Mir, G., O&#x2019;Connor, R.J., Dawes, H., et al.: LOng COvid Multidisciplinary consortium optimising treatments and servIces acrOss the NHS (Locomotion): protocol for a mixed-methods study in the UK. BMJ Open 12(5), e063505 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9114312</ArticleId><ArticleId IdType="pubmed">35580970</ArticleId></ArticleIdList></Reference><Reference><Citation>European Burden of Disease Network. Burden of disease of COVID-19: Protocol for country studies. In: Technology ECiS, editor. 2020.</Citation></Reference><Reference><Citation>Wyper G, Assun&#xe7;&#xe3;o R, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. International Journal of Public Health. 2021:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8565264</ArticleId><ArticleId IdType="pubmed">34744580</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeles, M.R., Wanni Arachchige Dona, S., Nguyen, H.D., Le, L.K.-D., Hensher, M.: Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan. BMC Public Health 22(1), 1&#x2013;13 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9009167</ArticleId><ArticleId IdType="pubmed">35421963</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes: Oxford university press; 2015.</Citation></Reference><Reference><Citation>Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation: Oup Oxford; 2006.</Citation></Reference><Reference><Citation>Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. 2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">15361314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan, M., Parkin, A., Makower, S., Greenwood, D.C.: Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: A cross-sectional evaluation from a community COVID rehabilitation service. J. Med. Virol. 94(4), 1419&#x2013;1427 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>Straudi, S., Manfredini, F., Baroni, A., Milani, G., Fregna, G., Schincaglia, N., et al.: Construct validity and responsiveness of the COVID-19 Yorkshire rehabilitation scale (C19-YRS) in a cohort of Italian hospitalized COVID-19 Patients. Int. J. Environ. Res. Public Health 19(11), 6696 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9180312</ArticleId><ArticleId IdType="pubmed">35682280</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20(10), 1727&#x2013;1736 (2011)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez Alava M, Pudney S, Wailoo A. Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from an English Population Study. In: York UoSa, editor. Policy Research Unit in Economic Evaluation of Health and Care Interventions2020.</Citation></Reference><Reference><Citation>Ministry of Housing CaLG. English indices of deprivation 2019 2019. Available from: https://imd-by-postcode.opendatacommunities.org/imd/2019.</Citation></Reference><Reference><Citation>Office for National Statistics. UK SIC 2007 2022 [updated 24 January 2022]. Available from: https://www.ons.gov.uk/methodology/classificationsandstandards/ukstandardindustrialclassificationofeconomicactivities/uksic2007.</Citation></Reference><Reference><Citation>UK Care Guide. How Much Does in Home Care Cost in April 2023 2023 [updated 1 April 2023]. Available from: https://ukcareguide.co.uk/home-care-costs/.</Citation></Reference><Reference><Citation>StataCorp. Stata Statistical Software: Release 17. In: College Station TSL, editor. 2019.</Citation></Reference><Reference><Citation>Department for Work &amp; Pensions. Economic labour market status of individuals aged 50 and over, trends over time: September 2022 2022 [updated 8 September 2022]. Available from: https://www.gov.uk/government/statistics/economic-labour-market-status-of-individuals-aged-50-and-over-trends-over-time-september-2022/economic-labour-market-status-of-individuals-aged-50-and-over-trends-over-time-september-2022#economic-inactivity.</Citation></Reference><Reference><Citation>Thompson, E.J., Williams, D.M., Walker, A.J., Mitchell, R.E., Niedzwiedz, C.L., Yang, T.C., et al.: Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 13(1), 3528 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Babnik, K., Staresinic, C., Lep, &#x17d;: Some of the workforce face post COVID after the acute phase of the illness: the employer&#x2019;s supportive role. Hum. Syst. Manag. 41(2), 257&#x2013;275 (2022)</Citation></Reference><Reference><Citation>Kingdon, C.C., Bowman, E.W., Curran, H., Nacul, L., Lacerda, E.M.: Functional status and well-being in people with myalgic encephalomyelitis/chronic fatigue syndrome compared with people with multiple sclerosis and healthy controls. PharmacoEconomics-open. 2(4), 381&#x2013;392 (2018)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6249197</ArticleId><ArticleId IdType="pubmed">29536371</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrill, M., Wardley, A.M., Retzler, J., Smith, A.B., Bottomley, C., N&#xed; Dhochartaigh, S., et al.: Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage. Health Qual. Life Outcomes 18, 1&#x2013;12 (2020)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607622</ArticleId><ArticleId IdType="pubmed">33138835</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin SM, Crawley E, May MT, Sterne JA, Hollingworth W, Database UCMNO. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC health services research. 2011; 11:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3184626</ArticleId><ArticleId IdType="pubmed">21923897</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsekar, K., Wilsher, S.H., Sweeting, A., Patel, A., Fordham, R.: Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer. BMJ Open 11(1), e039412 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728345</ArticleId><ArticleId IdType="pubmed">33431487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane, M., Mitchell, E., Hollingworth, W., Crawley, E., Tr&#xe9;pel, D.: Cost-effectiveness of interventions for chronic fatigue syndrome or Myalgic encephalomyelitis: a systematic review of economic evaluations. Appl. Health Econ. Health Policy 19, 473&#x2013;486 (2021)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917957</ArticleId><ArticleId IdType="pubmed">33646528</ArticleId></ArticleIdList></Reference><Reference><Citation>Weatherly, H., Drummond, M., Claxton, K., Cookson, R., Ferguson, B., Godfrey, C., et al.: Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy 93(2&#x2013;3), 85&#x2013;92 (2009)</Citation><ArticleIdList><ArticleId IdType="pubmed">19709773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, M.P., McDaid, D., Ludbrook, A., Powell, J.: Economic appraisal of public health interventions. Health Development Agency, London (2005)</Citation></Reference><Reference><Citation>Norheim, O.F., Baltussen, R., Johri, M., Chisholm, D., Nord, E., Brock, D., et al.: Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Effect Resource Allocation. 12(1), 18 (2014)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4171087</ArticleId><ArticleId IdType="pubmed">25246855</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, A., Nirantharakumar, K., Hughes, S., Myles, P., Williams, T., Gokhale, K.M., et al.: Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28(8), 1706&#x2013;1714 (2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Murali, M., Gumber, L., Jethwa, H., Ganesh, D., Hartmann-Boyce, J., Sood, H., et al.: Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis. BMC Med. 21(1), 1&#x2013;18 (2023)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10049782</ArticleId><ArticleId IdType="pubmed">36978166</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir, G., Salway, S., Kai, J., Karlsen, S., Bhopal, R., Ellison, G.T., et al.: Principles for research on ethnicity and health: the Leeds Consensus Statement. European J Public Health. 23(3), 504&#x2013;510 (2013)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662014</ArticleId><ArticleId IdType="pubmed">22552261</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck, A., Crain, A.L., Solberg, L.I., Un&#xfc;tzer, J., Glasgow, R.E., Maciosek, M.V., et al.: Severity of depression and magnitude of productivity loss. Annals Family Med 9(4), 305&#x2013;311 (2011)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3133577</ArticleId><ArticleId IdType="pubmed">21747101</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J., Taylor, B., Palmer, A.J., Kirk-Brown, A., van Dijk, P., Simpson, S., Jr., et al.: Estimating MS-related work productivity loss and factors associated with work productivity loss in a representative Australian sample of people with multiple sclerosis. Mult. Scler. J. 25(7), 994&#x2013;1004 (2019)</Citation><ArticleIdList><ArticleId IdType="pubmed">29911469</ArticleId></ArticleIdList></Reference><Reference><Citation>Algamdi, M., Sadatsafavi, M., Fisher, J.H., Morisset, J., Johannson, K.A., Fell, C.D., et al.: Costs of workplace productivity loss in patients with fibrotic interstitial lung disease. Chest 156(5), 887&#x2013;895 (2019)</Citation><ArticleIdList><ArticleId IdType="pubmed">31051170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabes-Figuera, R., McCrone, P., Hurley, M., King, M., Donaldson, A.N., Ridsdale, L.: The hidden cost of chronic fatigue to patients and their families. BMC Health Serv. Res. 10(1), 1&#x2013;7 (2010)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2845126</ArticleId><ArticleId IdType="pubmed">20202216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, J.M.S., Resch, S.C., Brimmer, D.J., Johnson, A., Kennedy, S., Burstein, N., et al.: The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs. Cost Effectiveness Resou Allocation 9(1), 1&#x2013;12 (2011)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3033815</ArticleId><ArticleId IdType="pubmed">21251294</ArticleId></ArticleIdList></Reference><Reference><Citation>Close S, Marshall-Gradisnik S, Byrnes J, Smith P, Nghiem S, Staines D. The economic impacts of myalgic encephalomyelitis/chronic fatigue syndrome in an Australian cohort. Frontiers in Public Health. 2020: 420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472917</ArticleId><ArticleId IdType="pubmed">32974259</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>